Loading...
XETR
HNL
Market cap61mUSD
Jul 10, Last price  
8.88EUR
1D
0.23%
1Q
-3.90%
Jan 2017
-68.58%
IPO
-3.48%
Name

Dr Hoenle AG

Chart & Performance

D1W1MN
XETR:HNL chart
P/E
P/S
0.57
EPS
Div Yield, %
Shrs. gr., 5y
1.70%
Rev. gr., 5y
-0.04%
Revenues
94m
-5.11%
23,693,00026,246,00048,744,00044,985,00054,624,00067,878,00072,092,00078,130,00082,090,00092,173,00093,415,000101,926,000126,492,000107,747,00093,876,000115,170,000116,093,000106,342,00098,729,00093,682,000
Net income
-3m
L-76.15%
03,167,0004,569,000-4,083,0004,806,0006,879,0005,848,0006,620,0006,256,00010,128,0008,278,00010,427,00021,738,00012,477,0005,678,000-4,820,000-13,361,000-11,006,000-13,282,000-3,168,000
CFO
5m
-8.43%
4,326,0005,275,0001,886,000-3,096,0004,644,00010,293,0003,624,0005,363,0007,492,0009,159,0008,356,0006,579,00024,216,00016,924,0007,234,0001,130,000-7,406,0003,143,0005,530,0005,064,000
Dividend
Mar 25, 20220.2 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives division develops industrial bonding solutions for critical applications within sectors such as consumer electronics, medical technology, optics and opto-electronics, the automotive industry, and glass processing. Its Equipment & Systems segment focuses on developing solutions for the efficient drying of inks and coatings, the precise curing of adhesives and plastics, comprehensive surface disinfection, and advanced solar simulation. Lastly, the Glass & Lamps division manufactures quartz glass tubing and rods, which are vital for the lamp, automotive, semiconductor, and fiber optic cable industries, alongside producing specialized lamps utilized for water purification and the drying of various coatings and adhesives. Founded in 1976, Dr. Hönle AG is headquartered in Munich, Germany.
IPO date
Feb 25, 2008
Employees
581
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT